Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells

Oncogene

Volumn 16, Issue 8, 1998, Pages 985-990

  Fournes, Bénédicte ^a   Monier, Roger ^a   Michiels, Francine ^a   Milgrom, Edwin ^b   Misrahi, Micheline ^b   Feunteun, Jean ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

FRTL 5 cells; Gsp; Malignant transformation; TSH receptor

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; THYROTROPIN; THYROTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; GENE MUTATION; HUMAN; HYPERTHYROIDISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR GENE; THYROID ADENOMA; THYROID CELL;

ANIMALIA; BOVINAE; MUS MUSCULUS;

EID: 0032567947     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201626     Document Type: Article

References (39)

1. Ambesi-Impiombato F, Parks L and Coon H. (1980). Proc. Natl. Acad. Sci. USA, 77, 3455-3459.
2. Birnbaumer L, Abramowitz J and Brown A. (1990). Biochim. Biophys. Acta, 1031, 163-224.
3. De Roux N, Polak M, Couet J, Leger J, Czernichow P, Milgrom E and Misrahi M. (1996). J. Clin. Endocrinol. Metab., 81, 2023-2026.
4. Derwahl M, Broecker M, Aeschimann S, Schatz H and Studer H. (1992). Biochem. Biophys. Res. Commun., 183, 220-226.
5. Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, Schvartz C, Delisle M, Decoulx M, Orgiazzi J, Dumont J and Vassart G. (1994). Nat. Genet., 7, 396-401.
6. Freissmuth M and Gilman A. (1989). J. Biol. Chem., 264, 21907-21914.
7. Fusco A, Pinto A, Tramontano D, Tajana G, Vecchio G and Tsuchida N. (1982). Cancer Res., 42, 618-626.
8. Goretzki P, Lyons J, Stacy-Phipps S, Rosenau W, Demeure M, Clark O, McCormick F, Roher H and Bourne H. (1992). World J. Surg., 16, 576-581.
9. Hen R, Axel R and Obici S. (1989). Proc. Natl. Acad. Sci. USA, 86, 4785-4788.
10. Housley M and Milligan G. (1997). TIBS, 22, 217-224.
11. Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E, Jameson J, Dumont J and Vassart G. (1995). N. Engl. J. Med., 332, 150-154.
12. Laglia G, Zeiger M, Leipricht A, Caturegli P, Levine M, LD, LK and Saji M. (1996). Endocrinology, 137, 3170-3176.
13. Lundis C, Masters S, Spada A, Pace A, Bourne H and Vallar L. (1989). Nature, 340, 692-696.
14. Laugwitz K-L, Allgeir A, Offermanns S, Spicher K, Van Sande J, Dumont JE and Schultz G. (1996). Proc. Natl. Acad. Sci. USA, 93, 116-120.
15. Ledent C, Dumont J, Vassart G and Parmentier M. (1992). EMBO J., 11, 537-542.
16. Ledent C, Parmentier M and Vassart G. (1990). Proc. Natl. Acad. Sci. USA, 87, 6176-6180.
17. Loosfelt H, Pichon C, Jolivet A, Misrahi M, Caillou B, Jamous M, Vannier B and Milgrom E. (1992). Proc. Natl. Acad. Sci. USA, 89, 3765-3769.
18. Lyons J, Landis C, Harsh G, Vallar L, Grunewald K, Feichtinger H, QY, QD, Clark O, Kawasaki E, Bourne H and McCormik F. (1990). Science, 249, 655-659.
19. Michiels F, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury M, Schlumberger M, Mercken L, Monier R and Feunteun J. (1994). Proc. Natl. Acad. Sci. USA, 91, 10488-10492.
20. Muca C and Vallar L. (1994). Oncogene, 9, 647-653.
21. Ossendorp F, Bruning P, Schuuring E, Brink JVD, Heide Dvd, Vijlder JD and Bruin TD. (1990). Endocrinology, 127, 419-430.
22. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J and Vassart G. (1993). Nature, 365, 649-651.
23. Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J and Vassart G. (1995). Mol. Endocrinol., 9, 725-733.
24. Paschke R, Tonacchera M, Van Sande J, Parma J and Vassart G. (1994). J. Clin. Endocrinol. Metab., 79, 1785-1789.
25. Peter H, Gerber H, Studer H, Groscurth P and Zakarija M. (1991). Endocrinology, 128, 211-219.
26. Russo D, Arturi F, Wicker R, Chazenbalk G, Schlumberger M, DuVillard J, Caillou B, R RM, Rapoport B, Filetti S et al. (1995a). J. Clin. Endocrinol. Metab., 80, 1347-1351.
27. Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S and Suarez H. (1995b). Oncogene, 11, 1907-1911.
28. Saji M, Levine M and Zeiger M. (1994). Surgery, 116, 1048-1052.
29. Santisteban P, Kohn L and Di Lauro R. (1987). J. Biol. Chem., 262, 4048-4052.
30. Suarez H, Villard Jd, Caillou B, Schlumberger M, Parmentier C and Monier R. (1991). Oncogene, 6, 677-679.
31. Tonacchera M, Van Sande J, Cetani F, Swillens S, C CS, Winiszewski P, Portmann L, Dumont J, Vassart G and Parma J. (1996). J. Clin. Endocrinol. Metab., 81, 547-554.
32. Tsuzaki S, Cone R, Frazier A and Moses A. (1991). Endocrinology, 128, 1359-1368.
33. Van Biesen T, Hawes B, Luttrel D, Krueger K, Touhara K, Porfiri E, Sakaue M, Luttrel L and Lefkovitz R. (1995). Nature, 376, 781-784.
34. Vanhaesebroeck B, Leevers S, Panayotou G and Waterfield M. (1997). TIBS, 22, 267-272.
35. Vlahos C, Matter W, Hui K and Brown R. (1994). J. Biol. Chem., 269, 5241-5248.
36. Weigel R and deConinck EC. (1993). Cancer Res., 53, 3472-3474.
37. Wigler M, Pellicer A, Silverstein S and Axel R. (1978). Cell, 14, 725-731.
38. Zachary I, Masters S and Bourne H. (1990). Biochem. Biophys. Res. Commun., 168, 1184-1193.
39. Zeiger MA, Saji M, Catunegli P, Westra WH, Kohn LD and Levine MA. (1996). Endocrinology, 137, 5392-5399.